Type of sera | Total cases# n | Sera samples containing ATA against | |||||
p40–p42 | p36 | p30 | p28 | p26 | p14 | ||
NSCLC | 37 | 10 (28) | 3 (8) | 6 (16) | 0 (0) | 3 (8) | 6 (16) |
Breast cancer | 30 | 7 (23) | 0 (0) | 0 (0) | 0 (0) | 5 (17) | 0 (0) |
Endometrial cancer | 25 | 6 (24) | 0 (0) | 5 (20) | 0 (0) | 0 (0) | 0 (0) |
Cervical cancer | 25 | 5 (20) | 0 (0) | 3 (12) | 0 (0) | 1 (4) | 0 (0) |
Ovarian cancer | 25 | 7 (28) | 0 (0) | 1 (4) | 0 (0) | 2 (8) | 3 (12) |
Thyroid cancer | 25 | 4 (16) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Colon cancer | 25 | 4 (16) | 0 (0) | 3 (12) | 0 (0) | 0 (0) | 0 (0) |
Pulmonological disorders¶ | 36 | 13 (36) | 3 (8) | 3 (8) | 0 (0) | 6 (17) | 0 (0) |
Healthy individuals+ | 115 | 7 (6) | 0 (0) | 3 (3) | 0 (0) | 0 (0) | 0 (0) |
Data are presented as n (%) unless otherwise stated
#: total amount of individuals investigated are taken as 100%
¶: patients were irradiated during liquidation of consequences of the Chernobyl nuclear power plant incident
+: the data for healthy individuals, taken from table 1⇑ (screening by NCI-N417 cells,) are presented for comparison. NSCLC: nonsmall cell lung cancer